Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03525678
Title A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Subjects With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
GSK Investigational Site New Haven Connecticut 06510 United States Details
GSK Investigational Site Atlanta Georgia 30322 United States Details
GSK Investigational Site Atlanta Georgia 30342 United States Details
GSK Investigational Site Chicago Illinois 60612 United States Details
GSK Investigational Site Chicago Illinois 60637 United States Details
GSK Investigational Site Indianapolis Indiana 46202 United States Details
GSK Investigational Site Fairway Kansas 66205 United States Details
GSK Investigational Site Baton Rouge Louisiana 70121 United States Details
GSK Investigational Site Baltimore Maryland 21201 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site Rochester Minnesota 55905 United States Details
GSK Investigational Site New York New York 10029 United States Details
GSK Investigational Site New York New York 10065 United States Details
GSK Investigational Site Charlotte North Carolina 28204 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19104 United States Details
GSK Investigational Site Nashville Tennessee 37232 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site Salt Lake City Utah 84112 United States Details
GSK Investigational Site Seattle Washington 98109 United States Details
GSK Investigational Site Madison Wisconsin 53792 United States Details
GSK Investigational Site Woodville South Australia 5011 Australia Details
GSK Investigational Site Fitzroy Victoria 3065 Australia Details
GSK Investigational Site Melbourne Victoria 3004 Australia Details
GSK Investigational Site Calgary Alberta T2N 4N2 Canada Details
GSK Investigational Site Winnipeg Manitoba R3E 0V9 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Lille 59037 France Details
GSK Investigational Site Nantes cedex 1 44093 France Details
GSK Investigational Site Paris 75010 France Details
GSK Investigational Site Pessac cedex 33600 France Details
GSK Investigational Site Pierre BEnite 69495 France Details
GSK Investigational Site Toulouse cedex 9 31059 France Details
GSK Investigational Site Dresden 01307 Germany Details
GSK Investigational Site Hannover 30625 Germany Details
GSK Investigational Site Koblenz 56068 Germany Details
GSK Investigational Site Schwerin 19049 Germany Details
GSK Investigational Site Tuebingen 72076 Germany Details
GSK Investigational Site Wuerzburg 97080 Germany Details
GSK Investigational Site Aviano PN 33081 Italy Details
GSK Investigational Site Parma 43126 Italy Details
GSK Investigational Site Rionero In Vulture PZ 85028 Italy Details
GSK Investigational Site Torino 10126 Italy Details
GSK Investigational Site Badalona 08916 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Granada 18014 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Madrid 28223 Spain Details
GSK Investigational Site Murcia 30008 Spain Details
GSK Investigational Site PamplonaNavarra 31008 Spain Details
GSK Investigational Site Salamanca 37007 Spain Details
GSK Investigational Site Valencia 46017 Spain Details
GSK Investigational Site Birmingham B9 5SS United Kingdom Details
GSK Investigational Site Bournemouth BH7 7DW United Kingdom Details
GSK Investigational Site London NW1 2BU United Kingdom Details
GSK Investigational Site Nottingham NG5 1PB United Kingdom Details
GSK Investigational Site Oxford OX3 7LE United Kingdom Details
GSK Investigational Site Stoke on Trent ST4 6QG United Kingdom Details
GSK Investigational Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field